Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a robot help stroke survivors with HIV walk again?

NCT ID NCT04488250

Symptom relief Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial explores whether an affordable robot can help people with HIV who have had a stroke improve their arm and leg function. Participants will use the robot for rehabilitation exercises, and researchers will measure changes in movement, balance, and quality of life. The goal is to see if this technology is practical and beneficial in settings like Botswana, where rehab access is limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robot-assisted rehabilitation therapy using an affordable robotic device
What this could lead to
If successful, this could make robot-assisted rehab widely available in low-resource settings, helping stroke survivors with HIV regain mobility and independence.
What could go wrong
This is a small feasibility study, so results may not apply broadly. The robot may not be as effective as traditional therapy, and technical or acceptance issues could arise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2020

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * diagnosis of Stroke (at least 3 months post incident) with or without HIV, age over 18; * medically stable (Able to tolerate therapy and given the determination as able to go through protocol by physician); * have neurological function between 5 and 24 as defined by the NIH Stroke Scale (NIHSS); * have no less than moderate cognitive function as defined by the International HIV-Dementia Scale * Able to give consent. Exclusion Criteria: * unable to give consent; * severely depressed (Becks Depression Inventory-Fast Screener); * experiencing excessive pain (Visual Analog Scale (VAS) score greater than 4); * have severe spasticity ( than 3) in muscle tone in elbow/shoulder/wrist hip/knee/ankle using the Ashworth Scale; * have total paralysis or muscular contractures of upper or lower extremity; * have a history of psychiatric disorder or cardiac problems; * have a history of prior brain injury including lesions to the cerebella or brain stem; * have open lesions on the upper or lower limbs; * It is up to the physician to decide if a subject should be excluded due to severe drug and/or alcohol abuse or taking of medication that would impair cognitive ability.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS Stroke

Contacts and locations

Locations

  • Penn Medicine Rittenhouse

    Philadelphia, Pennsylvania, 19146, United States

  • University of Botswana

    Gaborone, Botswana

More trials for these conditions

Other studies related to the condition(s) this trial covers.